Skip to main content
Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 002720 ISIN · KR7002720001 KO Manufacturing
Filings indexed 297 across all filing types
Latest filing 2023-03-16 Annual Report
Country KR South Korea
Listing KO 002720

About Kukje Pharma Co., Ltd.

https://www.kukjepharm.co.kr/index.php?…

Kukje Pharma Co., Ltd. is a company engaged in the manufacturing, distribution, import, and export of pharmaceutical products, cosmetics, and health supplements. Its core offerings include a wide range of prescription (ETC) and over-the-counter (OTC) drugs, with a notable specialization in antibiotics such as Cephalosporins. In addition to its primary pharmaceutical business, the company also develops and markets cosmetic products, food supplements, and respiratory protection face masks. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for Kukje Pharma Co., Ltd. for the fiscal year 2022 (65th term). It contains comprehensive financial data, management discussion, business overview, and operational details, which are characteristic of an Annual Report (10-K equivalent in the Korean regulatory context). FY 2022
2023-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Kukje Pharma. It provides the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, revenue, profit) for both consolidated and separate financial statements. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and submission of the audit report to the exchange, rather than the full annual report document itself. Given the structure and the nature of the announcement, it fits the 'Audit Report / Information' category. FY 2022
2023-03-15 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation & Information Statement). It contains details regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, voting procedures (electronic voting/proxy), and financial statements (balance sheets, income statements) provided as reference material for shareholders to make informed voting decisions. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2023-02-28 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Kukje Pharma regarding a 'Bonus Issue' (무상증자결정). This involves the issuance of new shares to existing shareholders, which falls under capital changes. Since it specifically details a bonus issue (a type of share issuance/capital change), it is classified as a Share Issue/Capital Change announcement.
2023-02-28 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Kukje Pharma. It outlines the date, location, and agenda items (financial statements, director appointments, and remuneration limits) for the upcoming Annual General Meeting. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items.
2023-02-23 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Kukje Pharm Co., Ltd. It contains the meeting agenda, date, location, and detailed management information including board activities, remuneration, and financial statements for the upcoming AGM. This document is a formal proxy statement/notice sent to shareholders to inform them of the meeting and request their participation/votes, which aligns with the definition of a Proxy Solicitation & Information Statement.
2023-02-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.